EUVIMEDEUVIMED entdecken
LeserbriefÜbersichtsarbeit

Fluorescence Resonance Energy Transfer Assay at the Crossroad: Urgent Reexamination of Assay Design for Severe Acute Respiratory Syndrome Coronavirus 2 Main Protease Inhibitors

Jiankai Ye, Tao Xu, Chunlei Xu, Xiaoping Liu, Yunyu Chen iD

Journal of Medical Virology · 2026

DOI: 10.1002/jmv.70801 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of Medical Virology, 2026. Verfasst von Jiankai Ye und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Drug Screening and Evaluation, Wannan Medical College, Wuhu, China. Hauptthemen laut MEDLINE: Antiviral Agents, COVID-19 Drug Treatment, Fluorescence Resonance Energy Transfer, Protease Inhibitors. Die Arbeit nennt 32 Literaturangaben. Gefördert von: University Natural Science Research Project of Anhui Province, China, Outstanding Young Graduate Supervisors Program of Anhui Province, China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The main protease (Mpro) from coronaviruses represents an attractive therapeutic target for antiviral development. The fluorescence resonance energy transfer (FRET) assay is widely used for high‐throughput screening (HTS) of Mpro inhibitors, but there has been a significant increase in false positives stemming from flawed assay design in previous studies. Here, we provide an overview of the FRET assay, discuss the key points of this method design, and highlight the corresponding solutions. We hope that this issue should receive increased attention from researchers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsCOVID-19 Drug TreatmentFluorescence Resonance Energy TransferProtease InhibitorsSARS-CoV-2HumansCoronavirus 3C ProteasesCOVID-19High-Throughput Screening Assays

Stichwörter der Autor:innen

SARS‐CoV‐2assay designcolloidal aggregationfluorescence quenchingfluorescence resonance energy transfermain protease inhibitor

Substanzen

Antiviral AgentsCoronavirus 3C ProteasesProtease Inhibitors

Autor:innen und Institutionen

  • Laboratory for Drug Screening and Evaluation, Wannan Medical College, Wuhu, China.

ORCID-Profile: Yunyu Chen

Förderung

  • University Natural Science Research Project of Anhui Province, China
  • Outstanding Young Graduate Supervisors Program of Anhui Province, China

Zitieren

APA

Ye, J., Xu, T., Xu, C., Liu, X., & Chen, Y. (2026). Fluorescence Resonance Energy Transfer Assay at the Crossroad: Urgent Reexamination of Assay Design for Severe Acute Respiratory Syndrome Coronavirus 2 Main Protease Inhibitors. Journal of Medical Virology. https://doi.org/10.1002/jmv.70801

Vancouver

Ye J, Xu T, Xu C, Liu X, Chen Y. Fluorescence Resonance Energy Transfer Assay at the Crossroad: Urgent Reexamination of Assay Design for Severe Acute Respiratory Syndrome Coronavirus 2 Main Protease Inhibitors. Journal of Medical Virology. 2026. doi:10.1002/jmv.70801

BibTeX
@article{Ye2026,
  author = {Ye, Jiankai and Xu, Tao and Xu, Chunlei and Liu, Xiaoping and Chen, Yunyu},
  title = {Fluorescence Resonance Energy Transfer Assay at the Crossroad: Urgent Reexamination of Assay Design for Severe Acute Respiratory Syndrome Coronavirus 2 Main Protease Inhibitors},
  journal = {Journal of Medical Virology},
  year = {2026},
  doi = {10.1002/jmv.70801}
}
Kostenlos starten →